dr. kahl on treatment strategies for indolent lymphoma
Published 4 years ago • 153 plays • Length 1:17Download video MP4
Download video MP3
Similar videos
-
0:50
dr. rosenthal on treatment strategies for indolent lymphomas
-
2:03
dr. kahl on considerations for treatment strategies in cll
-
1:25
dr. kahl on remaining challenges in indolent non-hodgkin lymphoma
-
1:49
dr. kahl discusses the construction of adcs for lymphoma treatment
-
1:42
dr. kahl on adct-402 for relapsed/refractory b-cell non-hodgkin lymphoma
-
1:31
dr. kahl on efficacy of targeted agents in relapsed/refractory indolent lymphomas
-
5:33
management of refractory follicular lymphoma
-
1:33
dr. kahl on the utility of tafasitamab/lenalidomide in dlbcl
-
1:25
targeted therapy for the treatment of follicular lymphoma
-
8:04
refining therapeutic strategies for follicular lymphoma
-
1:32
dr. kahl on findings from the l-mind study with tafasitamab in dlbcl
-
1:53
dr. kahl on frontline btk inhibitor selection in cll
-
4:54
options for upfront therapy in mcl
-
0:54
dr. kahl on patient preference in treatment selection for cll
-
3:16
non-intensive treatment approaches in mantle cell lymphoma
-
6:15
therapy for relapsed follicular lymphoma
-
1:33
dr. reeder on future treatment approaches in aggressive lymphomas
-
6:18
treatment of follicular lymphoma
-
2:37
potential second-line treatment for indolent lymphoma